EAM Investors’s XBiotech XBIT Stock Holding History

EAM Investors’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,408	Closed	-$754K	–	292
2019 Q4	$754K	Sell	40,408 -22,700	-36%	-$292K	0.17%	224
2019 Q3	$660K	Buy	63,108 +1,781	+3%	+$14.5K	0.17%	213
2019 Q2	$465K	Sell	61,327 -29,023	-32%	-$252K	0.11%	241
2019 Q1	$996K	Sell	90,350 -35,216	-28%	-$286K	0.24%	187
2018 Q4	$638K	Buy	+125,566	New	+$515K	0.17%	225

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

EAM Investors's XBIT Position: Q1 2020 in Review

EAM Investors sold out of XBiotech (XBIT) in Q1 2020, closing a stake of 40,408 shares — an estimated $754K sold.

EAM Investors first reported a position in XBIT in Q4 2018 and held it in 5 quarters. The position peaked at $996K in Q1 2019. 60 funds tracked by Wall St. Rank hold XBIT as of Q1 2020.

EAM Investors reported no remaining XBiotech position as of Q1 2020 after selling out during the quarter.
EAM Investors sold 40,408 XBiotech shares in Q1 2020, an estimated $754K.
EAM Investors first reported a position in XBiotech in Q4 2018 and held it in 5 quarters.
EAM Investors's XBiotech position peaked at $996K in Q1 2019.
60 funds tracked by Wall St. Rank held XBiotech as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.